Fresenius SE & Co. KGaA (FSNPF.PK), a health care company, on Wednesday reported higher earnings for the full year, supported by growth in revenue.
Group EBIT increased 4% to €2.595 billion from €2.489 billion a year ago, reflecting contributions from Fresenius Kabi's Growth Vectors and performance at Fresenius Helios in Spain.
Core net income grew 11% to €1.619 billion, or €2.87 per share from €1.461 billion or €2.59 per share last year.
Group revenue rose 5% to €22.554 billion from €21.526 billion. On an organic basis, revenue grew 7%.
The company plans to propose a dividend of €1.05 per share for fiscal 2025, 5% up year-on-year.
For fiscal 2026, Fresenius expects organic revenue growth of 4% to 7% and constant currency Core EPS growth of 5% to 10%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.